International research group led by Professor Chen has developed a new generation of potentially safer and more cost-effective therapies against West Nile virus etc, and other pathogens.

Scientists applied therapy based on monoclonal antibodies and their derivatives.

For the purposes of the study monoclonal antibodies are derived from tobacco plants, which is promising to change the image of the plant, which are believed to cause cancer of the lung.

The antibodies are directed against proteins located on the surface of the virus.

The main objective of the study is to create innovative, sustainable and affordable therapy that also be a cheap solution to combat the global threat of West Nile virus.

One approach is the development of therapeutic antibodies that bind to receptors which may help of the monoclonal antibodies to cross into the brain.

In a new study, the researchers developed a half-dozen new options that could assist in the implementation monoclonal antibodies that can be effectively targeted to the brain and to neutralize the dangerous virus.

The final results of the study show 90% success in preventing letalnit development in experimental conditions.

This is the first case of such an effect, leading to the neutralization of the virus.

Dr. Chen results are motivating the development of plant-based therapy that dramatically reduce the cost of commercial production of monoclonal antibodies.

The virus is spread by infected mosquitoes and affect the central nervous system.

Infection can cause serious, life-altering and even fatal disease.

Until now, however, is not available or effective drug therapy for dealing with infection.